In a recent issue of Cancer Discovery, Kato et al. identified recurrent activating mutations and copy gains in EHMT2, which encodes G9a, and such alterations were shown to drive oncogenesis in human melanoma [6]. This evidence concerns the gene EHMT2 and melanoma.